Efficacy of sirolimus in an infant with Kasabach–Merritt phenomenon

Chisa Kumagai; Michio Ozeki; Akifumi Nozawa; Hiromi Kakuda; Toshiyuki Fukao

doi:10.1111/ped.13630

journal article Aug 08, 2018

Efficacy of sirolimus in an infant with Kasabach–Merritt phenomenon

Chisa Kumagai

Michio Ozeki Akifumi Nozawa Hiromi Kakuda Toshiyuki Fukao

Pediatrics International Vol. 60 No. 9 pp. 887-889 · Wiley

View at Publisher Save 10.1111/ped.13630

Topics

No keywords indexed for this article. Browse by subject →

References

4

[1]

10.1016/j.jpeds.2013.03.080

[2]

10.1542/peds.2015-3257

[3]

10.1002/pbc.25296

[4]

10.1002/ijc.30775

Metrics

12

Citations

4

References

Details

Published: Aug 08, 2018
Vol/Issue: 60(9)
Pages: 887-889
License: View

Authors

C

Chisa Kumagai

Department of Pediatrics Gifu University Graduate School of Medicine Yanagido Japan; Department of Pediatrics Chuno Public Welfare Hospital Seki, Gifu Japan

M

Michio Ozeki

Department of Pediatrics Gifu University Graduate School of Medicine Yanagido Japan

A

Akifumi Nozawa

Department of Pediatrics Gifu University Graduate School of Medicine Yanagido Japan

H

Hiromi Kakuda

Department of Hematology/Oncology Chiba Children's Hospital Chiba Japan

T

Toshiyuki Fukao

Department of Pediatrics Gifu University Graduate School of Medicine Yanagido Japan

Cite This Article

Chisa Kumagai, Michio Ozeki, Akifumi Nozawa, et al. (2018). Efficacy of sirolimus in an infant with Kasabach–Merritt phenomenon. Pediatrics International, 60(9), 887-889. https://doi.org/10.1111/ped.13630

Efficacy of sirolimus in an infant with Kasabach–Merritt phenomenon

You May Also Like